Table 1.
Summary of reference articles regarding risk of diverticular bleed in DOAC use.
Author and Year | Method | Population Description | Total Population | Population with diverticular bleed | Population with bleed on DOAC (percentage) |
---|---|---|---|---|---|
Vajravelu et al 2018 [6] | Retrospective cohort study, 2000-2016 | Patients with diverticular hemorrhage | 14,925 | 14,925 | 237 (1.4%) |
| |||||
Nagata et al 2014 [7] | Prospective study 2009-2013 | Patients undergoing colonoscopy | 911 | 153 | 0∗ |
| |||||
Taki et al 2017 [8] | Retrospective case identification 2009-2016 | Patients with colonic diverticular bleeding and case-matched controls | 300 | 100 | 7 (2.3%) |
| |||||
Kumar et al 2015 [9] | Retrospective review all patients in a district hospital | Patients taking DOACS in a district hospital | 2,487 | 8∗∗ | 8 |
| |||||
Lai et al 2017 [10] | Retrospective review 2010-2015 | Patients taking DOACs | 21,503 | 52∗∗∗ | 52 |
| |||||
Brodie et al 2018 [11] | Retrospective review 2010-2016 | Patients with GI bleed | 8,496 | 31 | 2 (3.3%) |
∗only 2 patients in total were taking DOACs
∗∗54 total GI bleeds, 14% of which were related to diverticular disease
∗∗∗366 total GI bleeds